Contractors Report Problems With Los Angeles Wildfire Debris Cleanup
Contractors and a homeowner told NBC News that the Army Corps of Engineers did not properly remove debris after California wildfires. They expressed concern that toxins could remain in the soil. The statements come from an NBC News investigation.
yardbarker.comThe contractors and one homeowner said the cleanup did not meet standards needed to ensure the area was free of potential hazards. They raised specific worries that toxins could be left behind in the soil at affected sites.
The accounts were gathered as part of an NBC News investigation into the cleanup process following the wildfires. The concerns center on whether all contaminated materials were removed according to established protocols for such recovery efforts. Proper debris removal after wildfires typically involves checking for and disposing of ash, charred building materials and other substances that can leach chemicals into the ground.
Incomplete work can leave property owners and future residents exposed to health risks from lingering contamination. The contractors' statements highlight potential gaps between the scale of the disaster response and the thoroughness required for long-term environmental safety in the burned areas.
Homeowners in fire-affected neighborhoods rely on these cleanup operations before they can safely rebuild or return to their properties. Any shortcomings in the process can delay recovery and increase costs for those seeking to restore their homes.
Key Facts
Potential Impact
- 01
Homeowners may face delays in rebuilding on properties where cleanup concerns exist.
- 02
Further soil testing could be required at wildfire sites in Los Angeles.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…